Entirety Biomedical Closes $1.2M Seed Round to Advance AI-Enabled…

Team S · 2026-02-12T13:53:57.000Z

Entirety Biomedical, an early-stage medtech startup developing AI-enhanced biomedical devices and data solutions, has successfully closed a $1.2 million seed financing round to accelerate product development, advance clinical validation efforts, and expand partnerships with healthcare providers and research institutions. The funding will help the company scale its engineering, regulatory and go-to-market teams as it brings next-generation diagnostic and procedural tools to market. The seed round attracted participation from a group of institutional and strategic investors focused on healthcare innovation, AI-driven device platforms and clinical outcomes. Entirety Biomedical’s solutions leverage advanced signal processing, machine learning and real-time data analytics to enhance diagnostic precision while reducing user burden in clinical settings. With this new capital, the startup plans to expand its product pipeline and strengthen engagements with hospital systems and medical device partners across global markets.

Member Login Get Access

Entirety Biomedical Closes $1.2M Seed Round to Advance AI-Enabled… | Newnex